Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Liver Cancer|June 24, 2026
Real-World Treatment Patterns and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma: Results from the OREIOS StudyStephen Lam Chan, Valeriy Breder, Yu-Yun Shao, et al.
Growth Factors (Chur, Switzerland)|July 9, 2016
Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progressionRana Ahmed Youness, Mai Atef Rahmoon, Reem Amr Assal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 19, 2023
Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost-effectiveness modelSameera Ezzat, Ivane Gamkrelidze, Alaa Osman, et al.
The Pan African Medical Journal|January 15, 2019
Health: redefinedObinna Ositadimma Oleribe, Omole Ukwedeh, Nicholas Jonathan Burstow, et al.
Plos One|July 1, 2014
Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjectsIman F Galal, Zainab Zakaria, Walaa R Allam, et al.
Journal of Clinical Gastroenterology|February 9, 2026
Risk Stratification and Validation of ICU Scores in Prediction of Post-ERCP Mortality for Critically Ill Patients With Severe Acute Cholangitis Based on Tokyo Guidelines 2018Esam Elshimi, Tamer Refaat Fouad, Wael M Abdel-Razek, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 5, 2013
Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infectionSayed F Abdelwahab, Mohamed Hashem, Iman Galal, et al.
Journal of Hepatocellular Carcinoma|December 5, 2018
Sorafenib plus tegafur-uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)Hamdy A Azim, Ashraf Omar, Hesham Atef, et al.
Journal of Hepatocellular Carcinoma|October 27, 2025
P-ART Score is a New Modification to Improve ART Score Predictive Accuracy for Patients with HCC Undergoing TACEAhmed Attia, Esam Ali Elshimi, Zeinab Mohamed Seif Eldin, et al.
Archives of Virology|June 4, 2018
Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among EgyptiansShaimaa Hamdy, Ahmed M Osman, Zainab A Zakaria, et al.
Pageof 11